Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-21

Clinical Trial Update: Pirfenidone and Its Role in Burn Wound Healing [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pirfenidone for burn wound healing has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pirfenidone (Esbriet) (pirfenidone)

Snippet

Sponsor: Universidad Autonoma de Nuevo Leon | Conditions: Second-degree Burn | Phase 2 | Status: COMPLETED